SuperworthFMC EPS FMC
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- −$22.00
- Latest quarter, Q2 FY26
- −$1.49
- −381% on a year earlier
- Fiscal year 2025
- −$17.85
- −756% on the year before
FMC's earnings per share was −$22.00 over the twelve months to Jun 30, 2026, down 2850% on a year earlier.
In its latest quarter, Q2 FY26, it was −$1.49, down 381% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$17.85 | −756% |
| FY2024 | $2.72 | −74% |
| FY2023 | $10.53 | +81% |
| FY2022 | $5.82 | +1% |
| FY2021 | $5.74 | +36% |
| FY2020 | $4.22 | +17% |
| FY2019 | $3.61 | −2% |
| FY2018 | $3.70 | −7% |
| FY2017 | $3.99 | +156% |
| FY2016 | $1.56 | −57% |
| FY2015 | $3.62 | +58% |
| FY2014 | $2.29 | +8% |
| FY2013 | $2.13 | −29% |
| FY2012 | $3.00 | +18% |
| FY2011 | $2.55 | +117% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$1.49 | −381% | −$22.00 | |
| Q1 FY26 | −$2.25 | n/a | −$19.98 | |
| Q4 FY25 | −$13.74 | n/a | −$17.85 | |
| Q3 FY25 | −$4.52 | −969% | −$4.24 | |
| Q2 FY25 | $0.53 | −77% | $0.80 | |
| Q1 FY25 | −$0.12 | n/a | $2.62 | |
| Q4 FY24 | −$0.13 | −101% | $2.72 | |
| Q3 FY24 | $0.52 | n/a | $11.62 | |
| Q2 FY24 | $2.35 | +879% | $11.07 | |
| Q1 FY24 | −$0.02 | −101% | $8.96 | |
| Q4 FY23 | $8.77 | +304% | $10.53 | |
| Q3 FY23 | −$0.03 | −103% | $3.93 |
Against its peers
Companies in Chemicals nearest FMC's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| FMCFMC | −$22.00 | −2850% a year |
| FTKFlotek Industries | $0.99 | +125% a year |
| CRONCronos | $0.20 | +300% a year |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| ROGRogers | $1.75 | |
| NGVTIngevity | $1.47 | |
| IOSPInnospec | $4.90 | +545% a year |
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| AVNTAvient | $1.85 | +43% a year |
| CBTCabot | $3.54 | −54% a year |
| Peer median | $1.80 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on FMC
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.